New Zealand gives provisional nod to AstraZeneca's COVID-19 vaccine

FILE PHOTO: Boxes of AstraZeneca’s vaccine against the coronavirus disease (COVID-19) are seen at a walk-in vaccination centre in Algiers, Algeria June 6, 2021. REUTERS/Ramzi Boudina/File Photo

WELLINGTON (Reuters) – New Zealand’s health regulator Medsafe has granted provisional approval for the AstraZeneca COVID-19 vaccine for individuals 18 years of age and older, acting minister for COVID-19 response, Dr Ayesha Verrall, said on Thursday.

New Zealand secured 7.6 million doses of the AstraZeneca COVID-19 vaccine through an advance purchase agreement with the company last year.

The country has only been using the Pfizer/BioNTech COVID-19 vaccine so far.

Source: Read Full Article